Medline MDLN
NASDAQ MDLN
$32.85 -1.20 (-3.52%)
As of: Sep 10, 2026 · 1:44 PM EDT

Medline (MDLN) Enterprise Value (2025 - 2026)

Medline's (MDLN) quarterly Enterprise Value came in at $55.9 billion in Q2 2026, down 7.07% quarter-over-quarter from $60.2 billion in Q1 2026.

Analysis

Medline (MDLN) Enterprise Value (2025 - 2026) Analysis & Trends

Medline (MDLN) has reported Enterprise Value for 2 consecutive years, with $55.9 billion the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Enterprise Value changed N/A year-over-year to $55.9 billion in Q2 2026; TTM through Jun 2026 was $55.9 billion, a N/A change from a year earlier, with the FY2025 full-year figure at $61.8 billion, changed N/A from the prior year.
  • Enterprise Value was $55.9 billion for Q2 2026 at Medline, down from $60.2 billion in the prior quarter.
  • Over five years, Enterprise Value peaked at $61.8 billion in Q4 2025 and troughed at $55.9 billion in Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Becton Dickinson 48.30 Bn 47.44 Bn 2.32 Bn
2 Medline 28.17 Bn 25.50 Bn 2.22 Bn
3 West Pharmaceutical Services 24.11 Bn 23.67 Bn 329.20 Mn
4 Baxter International 12.46 Bn 10.31 Bn 1.03 Bn
5 Stevanato Group S.p.A 5.62 Bn 5.51 Bn 100.91 Mn
6 Acme United 235.96 Mn 230.92 Mn 26.69 Mn
7 Rockwell Medical 29.73 Mn 4.93 Mn 3.24 Mn
8 Retractable Technologies 21.15 Mn -18.72 Mn 190,852.00
9 United Health Products 8.85 Mn 8.82 Mn -
10 Cuprina Holdings (Cayman) 7.88 Mn 4.76 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 55.93 Bn
Mar 28, 2026 60.19 Bn
Dec 31, 2025 61.80 Bn